Department of Orthopaedics, Rehabilitation and Physical Therapy, Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, 2300 RC, Leiden, The Netherlands.
The Hague University of Applied Sciences, The Hague, The Netherlands.
Rheumatol Int. 2023 May;43(5):803-824. doi: 10.1007/s00296-022-05241-x. Epub 2022 Dec 1.
To assess the reporting quality of interventions aiming at promoting physical activity (PA) using a wearable activity tracker (WAT) in patients with inflammatory arthritis (IA) or hip/knee osteoarthritis (OA). A systematic search was performed in eight databases (including PubMed, Embase and Cochrane Library) for studies published between 2000 and 2022. Two reviewers independently selected studies and extracted data on study characteristics and the reporting of the PA intervention using a WAT using the Consensus on Exercise Reporting Template (CERT) (12 items) and Consolidated Standards of Reporting Trials (CONSORT) E-Health checklist (16 items). The reporting quality of each study was expressed as a percentage of reported items of the total CERT and CONSORT E-Health (50% or less = poor; 51-79% = moderate; and 80-100% = good reporting quality). Sixteen studies were included; three involved patients with IA and 13 with OA. Reporting quality was poor in 6/16 studies and moderate in 10/16 studies, according to the CERT and poor in 8/16 and moderate in 8/16 studies following the CONSORT E-Health checklist. Poorly reported checklist items included: the description of decision rule(s) for determining progression and the starting level, the number of adverse events and how adherence or fidelity was assessed. In clinical trials on PA interventions using a WAT in patients with IA or OA, the reporting quality of delivery process is moderate to poor. The poor reporting quality of the progression and tailoring of the PA programs makes replication difficult. Improvements in reporting quality are necessary.
评估使用可穿戴活动追踪器 (WAT) 促进炎症性关节炎 (IA) 或髋/膝骨关节炎 (OA) 患者身体活动 (PA) 的干预措施报告质量。在 2000 年至 2022 年间,我们在 8 个数据库(包括 PubMed、Embase 和 Cochrane Library)中进行了系统搜索,以寻找相关研究。两位审查员独立选择研究,并使用共识运动报告模板 (CERT)(12 项)和临床试验报告统一标准 (CONSORT) 电子健康清单(16 项)提取关于使用 WAT 干预 PA 的研究特征和报告数据。每个研究的报告质量用 CERT 和 CONSORT E-Health 报告项目的百分比表示(<50%=差;51-79%=中;80-100%=好)。纳入了 16 项研究;其中 3 项涉及 IA 患者,13 项涉及 OA 患者。根据 CERT,6/16 项研究的报告质量差,10/16 项研究的报告质量中等;根据 CONSORT E-Health 清单,8/16 项研究的报告质量差,8/16 项研究的报告质量中等。报告较差的清单项目包括:用于确定进展和起始水平的决策规则的描述、不良事件的数量以及如何评估依从性或保真度。在使用 WAT 对 IA 或 OA 患者进行 PA 干预的临床试验中,传递过程的报告质量中等至较差。PA 计划进展和定制的报告质量差使得复制变得困难。需要提高报告质量。